Percentage of women in executive committees and in line management, OLS analysis (models A and B), probability of female CEO and logistic regression (model C)
| % of women in executive committees | % of women in line management | Female CEO | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Model A1 | Model A2 | Model B1 | Model B2 | Marginal effects Model C1 | Marginal effects Model C2 | |||||||
| β | SE | β | SE | β | SE | β | SE | % | SE | % | SE | |
| Company type | ||||||||||||
| Non-CBQ companies (ref) | ||||||||||||
| CBQ_Listed | −3.80 | 2.76 | 6.09 | 3.31 | −3.28 | 3.09 | −8.42* | 3.66 | −1.00 | 5.93 | −9.97 | 6.71 |
| CBQ_Cooperatives | −5.14 | 4.51 | −7.29 | 4.82 | −10.40* | 5.05 | −15.22** | 5.32 | −4.85 | 7.50 | −12.71 | 7.59 |
| CBQ_State- or Municipality-owned | 9.07 | 4.63 | 6.99 | 4.91 | 13.05* | 5.18 | 8.39 | 5.42 | 15.50 | 12.10 | 3.79 | 10.95 |
| Female Chair | 11.76** | 3.56 | 11.64** | 3.56 | 17.17*** | 3.99 | 16.91** | 3.93 | 21.09* | 10.08 | 19.48* | 9.06 |
| Share Women Board (Ex. Dep and Chair) | – | – | 0.09 | 0.07 | – | – | 0.21* | 0.08 | – | – | 0.47** | 0.18 |
| Revenue | ||||||||||||
| Less than 3m NOK (ref) | ||||||||||||
| 3–4.999m NOK | −9.15* | 4.33 | −9.20* | 4.32 | −6.89 | 4.84 | −6.99 | 4.78 | 0.96 | 10.16 | −0.02 | 10.02 |
| 5–9.999m NOK | −3.62 | 4.38 | −3.71 | 4.37 | −5.23 | 4.90 | −5.44 | 4.83 | 2.33 | 10.41 | 1.74 | 10.26 |
| 10m NOK or more | −5.93 | 4.67 | −5.43 | 4.68 | −4.51 | 5.22 | −3.39 | 5.17 | −1.07 | 10.43 | 0.51 | 10.47 |
| Number board (Ex. Dep.) | 1.85** | 0.61 | 1.72** | 0.61 | 1.34* | 0.68 | 1.04 | 0.68 | 2.03 | 1.33 | 1.98 | 1.36 |
| Number executive committee | 0.02 | 0.47 | 0.00 | 0.47 | −0.74 | 0.52 | −0.79 | 0.52 | −0.36 | 1.08 | −0.32 | 1.01 |
| Constant | 19.18*** | 5.33 | 18.00** | 5.41 | 19.80** | 5.96 | 17.16** | 5.97 | ||||
| N | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Adj. R2/Pseudo R2 | 0.156 | 0.158 | 0.160 | 0.183 | 0.097 | 0.142 | ||||||
| % of women in executive committees | % of women in line management | Female CEO | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Model A1 | Model A2 | Model B1 | Model B2 | Marginal effects | Marginal effects | |||||||
| SE | SE | SE | SE | % | SE | % | SE | |||||
| Company type | ||||||||||||
| Non-CBQ companies (ref) | ||||||||||||
| CBQ_Listed | −3.80 | 2.76 | 6.09 | 3.31 | −3.28 | 3.09 | −8.42 | 3.66 | −1.00 | 5.93 | −9.97 | 6.71 |
| CBQ_Cooperatives | −5.14 | 4.51 | −7.29 | 4.82 | −10.40 | 5.05 | −15.22 | 5.32 | −4.85 | 7.50 | −12.71 | 7.59 |
| CBQ_State- or Municipality-owned | 9.07 | 4.63 | 6.99 | 4.91 | 13.05 | 5.18 | 8.39 | 5.42 | 15.50 | 12.10 | 3.79 | 10.95 |
| Female Chair | 11.76 | 3.56 | 11.64 | 3.56 | 17.17 | 3.99 | 16.91 | 3.93 | 21.09 | 10.08 | 19.48 | 9.06 |
| Share Women Board | – | – | 0.09 | 0.07 | – | – | 0.21 | 0.08 | – | – | 0.47 | 0.18 |
| Revenue | ||||||||||||
| Less than 3m NOK (ref) | ||||||||||||
| 3–4.999m NOK | −9.15 | 4.33 | −9.20 | 4.32 | −6.89 | 4.84 | −6.99 | 4.78 | 0.96 | 10.16 | −0.02 | 10.02 |
| 5–9.999m NOK | −3.62 | 4.38 | −3.71 | 4.37 | −5.23 | 4.90 | −5.44 | 4.83 | 2.33 | 10.41 | 1.74 | 10.26 |
| 10m NOK or more | −5.93 | 4.67 | −5.43 | 4.68 | −4.51 | 5.22 | −3.39 | 5.17 | −1.07 | 10.43 | 0.51 | 10.47 |
| Number board (Ex. Dep.) | 1.85 | 0.61 | 1.72 | 0.61 | 1.34 | 0.68 | 1.04 | 0.68 | 2.03 | 1.33 | 1.98 | 1.36 |
| Number executive committee | 0.02 | 0.47 | 0.00 | 0.47 | −0.74 | 0.52 | −0.79 | 0.52 | −0.36 | 1.08 | −0.32 | 1.01 |
| Constant | 19.18 | 5.33 | 18.00 | 5.41 | 19.80 | 5.96 | 17.16 | 5.97 | ||||
| 200 | 200 | 200 | 200 | 200 | 200 | |||||||
| Adj. | 0.156 | 0.158 | 0.160 | 0.183 | 0.097 | 0.142 | ||||||
*p < 0.05; **p < 0.01; *** p < 0.001; OLS analysis = ordinary least square analysis; CBQ = corporate board quotas for gender representation; Listed = publicly listed on the stock exchange; Coop = cooperative company; State/Muni = state- or municipality-owned company; non-CBQ = companies without board quotas
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.